GE HealthCare secures FDA clearance and CE mark for deep learning tech
GE HealthCare announced the FDA submission at the Radiological Society of North America’s (RSNA) 2024 meeting in December. Image credit:...
FDA
GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
GE HealthCare Technologies Inc. GEHC recently announced FDA approval for Optison, its polyethylene glycol (PEG)-free ultrasound enhancing agent, for use...
GE HealthCare gets FDA clearance for AI-powered image technology
Photo: Morsa Images/Getty Images GE HealthCare has announced that the Food and Drug Administration has granted clearance for its Aurora...
GE HealthCare announces FDA 510(k) clearance for Aurora, a new dual-head SPECT/CT system, and Clarify DL, its AI-powered Deep Learning image reconstruction technology
Aurora is designed to help clinicians see and do more, aiming to help expand the range of CT procedures available,...
GE HealthCare submits deep learning tech for FDA clearance
GE HealthCare has submitted a 510(k) application to the US Food and Drug Administration (FDA) for CleaRecon DL, a deep...
Singulair may be linked to severe mental health side effects: FDA study
If you or someone you know is struggling with suicidal thoughts, you can call the U.S. National Suicide Prevention Lifeline...
GE Healthcare wins FDA clearance for Alzheimer’s imaging software
Dive Brief: GE Healthcare has received 510(k) clearance for a tool designed to help clinicians assess people who may have...
GE Healthcare gets FDA nod for new PET imaging agent
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:...
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
GE HealthCare Technologies, Inc. GEHC announced that it has received FDA approval for Flyrcado (flurpiridaz F 18), a breakthrough positron...
